Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism.

van den Brom CE, Bulte CS, Loer SA, Bouwman RA, Boer C.

Cardiovasc Diabetol. 2013 Mar 4;12:42. doi: 10.1186/1475-2840-12-42. Review.

2.

Metabolic therapy for the diabetic patients with ischaemic heart disease.

Rosano GM, Vitale C, Volterrani M, Fini M.

Coron Artery Dis. 2005 Nov;16 Suppl 1:S17-21. Review.

PMID:
16340399
3.

Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging.

Rijzewijk LJ, van der Meer RW, Lamb HJ, de Jong HW, Lubberink M, Romijn JA, Bax JJ, de Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit JW, Diamant M.

J Am Coll Cardiol. 2009 Oct 13;54(16):1524-32. doi: 10.1016/j.jacc.2009.04.074.

4.

Energy metabolism in the normal and in the diabetic heart.

Barsotti A, Giannoni A, Di Napoli P, Emdin M.

Curr Pharm Des. 2009;15(8):836-40. Review.

PMID:
19275647
5.

Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.

Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD.

Biochim Biophys Acta. 2011 Jul;1813(7):1333-50. doi: 10.1016/j.bbamcr.2011.01.015. Epub 2011 Jan 20. Review.

6.

Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.

van der Meer RW, Rijzewijk LJ, de Jong HW, Lamb HJ, Lubberink M, Romijn JA, Bax JJ, de Roos A, Kamp O, Paulus WJ, Heine RJ, Lammertsma AA, Smit JW, Diamant M.

Circulation. 2009 Apr 21;119(15):2069-77. doi: 10.1161/CIRCULATIONAHA.108.803916. Epub 2009 Apr 6.

7.

Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.

Masi S, Lautamäki R, Guiducci L, Di Cecco P, Porciello C, Pardini S, Morales MA, Chubuchny V, Salvadori PA, Emdin M, Sironi AM, Knuuti J, Neglia D, Nuutila P, Ferrannini E, Iozzo P.

Diabetologia. 2012 Sep;55(9):2494-500. doi: 10.1007/s00125-012-2631-0. Epub 2012 Jul 1.

PMID:
22752026
8.

Inhalational anaesthetics and cardioprotection.

Weber NC, Schlack W.

Handb Exp Pharmacol. 2008;(182):187-207. doi: 10.1007/978-3-540-74806-9_9. Review.

PMID:
18175092
9.

Metabolic disarrangement in ischemic heart disease and its therapeutic control.

Ferrari R.

Rev Port Cardiol. 1998 Sep;17(9):667-84. Review.

PMID:
9834638
10.

Myocardial uptake and release of substrates in type II diabetics undergoing coronary surgery.

Szabó Z, Håkanson E, Jorfeldt L, Svedjeholm R.

Scand Cardiovasc J. 2001 Jul;35(3):207-11.

PMID:
11515695
11.

Rationale for a metabolic approach in diabetic coronary patients.

Stanley WC.

Coron Artery Dis. 2005 Nov;16 Suppl 1:S11-5. Review.

PMID:
16340398
12.

Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.

Niu YG, Evans RD.

J Physiol. 2009 Jul 1;587(Pt 13):3301-15. doi: 10.1113/jphysiol.2009.173542. Epub 2009 May 11.

13.

Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions.

Stanley WC, Lopaschuk GD, Hall JL, McCormack JG.

Cardiovasc Res. 1997 Feb;33(2):243-57. Review.

14.

[Myocardial protection by volatile anesthetics].

Preckel B, Müllenheim J, Schlack W.

Anaesthesiol Reanim. 2002;27(5):116-23. Review. German.

PMID:
12451935
15.

Early administration of trimetazidine may prevent or ameliorate diabetic cardiomyopathy.

Wenmeng W, Qizhu T.

Med Hypotheses. 2011 Feb;76(2):181-3. doi: 10.1016/j.mehy.2010.09.012. Epub 2010 Oct 6.

PMID:
20932648
16.

Metabolic (in)flexibility of the diabetic heart.

Larsen TS, Aasum E.

Cardiovasc Drugs Ther. 2008 Apr;22(2):91-5. doi: 10.1007/s10557-008-6083-1. Review.

PMID:
18247112
17.

Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.

Calvani M, Reda E, Arrigoni-Martelli E.

Basic Res Cardiol. 2000 Apr;95(2):75-83. Review.

PMID:
10826498
18.

Metabolic imaging in myocardial ischemia and heart failure.

Knuuti J, Tuunanen H.

Q J Nucl Med Mol Imaging. 2010 Apr;54(2):168-76. Review.

PMID:
20588213
19.

Cardiac fatty acid metabolism and ischemic memory imaging with nuclear medicine techniques.

Palaniswamy SS, Padma S.

Nucl Med Commun. 2011 Aug;32(8):672-7. doi: 10.1097/MNM.0b013e32834774e3. Review.

PMID:
21606884
20.

[Cardioprotection by anesthetics].

Hara T.

Masui. 2006 May;55(5):552-9. Japanese.

PMID:
16715909
Items per page

Supplemental Content

Write to the Help Desk